Philipp Wechner

Title: Innovations of Philipp Wechner

Introduction

Philipp Wechner is an accomplished inventor based in Innsbruck, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of affinity ligands and recombinant production processes. With a total of 2 patents, his work has garnered attention in various scientific communities.

Latest Patents

Wechner's latest patents include innovative technologies related to affinity matrices and the recombinant production of heterologous polypeptides. One of his patents discloses an affinity matrix comprising a solid phase and an affinity ligand with specific peptide bonds. This invention focuses on peptides with particular amino acid compositions, ensuring that they meet defined length criteria. Another patent relates to a process for producing a heterologous polypeptide by cultivating a bacterial host cell transformed with an expression vector. This process involves several steps, including the isolation and solubilization of inclusion bodies, followed by the induction of autoproteolytic cleavage to obtain the desired polypeptide.

Career Highlights

Throughout his career, Wechner has worked with notable companies such as Sandoz AG and Boehringer Ingelheim RCV GmbH & Co. KG. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Wechner has collaborated with esteemed colleagues, including Bernhard Auer and Clemens Achmüller. These partnerships have likely enhanced his research and innovation capabilities.

Conclusion

Philipp Wechner's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in the production of biotechnological products.